Company intelligence / Profile preview

Advanced Lipids

Karlshamn, Sweden

Ownership: Private
Development stage: Other

Overview

Advanced Lipids is a joint venture between AAK and IFF (formerly Enzymotec) that specializes in the development and production of high-quality lipid ingredients for infant formula. The company's primary product, INFAT, is an OPO (Oleic-Palmitic-Oleic) structured lipid that mimics the fat composition found in human breast milk. This specialized lipid structure is clinically proven to improve calcium absorption, enhance bone mineral density, and reduce crying and constipation in infants. Advanced Lipids combines AAK's global production capabilities with IFF's clinical research and enzymatic technology to serve the global pediatric nutrition market.

Therapeutic areas: EndocrinologyGastroenterologyMetabolic Disorders
Modalities: Lipids
Industry: Food & Nutrition

Partnerships

AAKIFF

Beyond the preview

Go deeper on Advanced Lipids.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Lipids.

Explore the full profile